Catalyst Wire Dossier Catalyst Wire Dossier

CIMERLI

RANIBIZUMAB-EQRN · Coherus BioSciences Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CIMERLI, covering 2022-08-02 to 2024-05-21. Get the full timeline:

Most recent: FDA Approved: CIMERLI — Supplemental Application (Coherus BioSciences Inc)

See pricing